Overview: The focus of this symposium was on the present and futurecapabilities of flow cytometry for both medical and biologicalapplications in cancer. This technology began with quite modestinstrumentation, with limited capabilities to answer biologicalquestions. Today, both the clinical workhorses and the powerfulmulti-laser, multi-detector, sorting machinery, coupled withsophisticated computers and storage devices and the increasingstorehouse of markers and dyes, are taking us to the limit and beyondin finding answers to the cause and cure of cancer. .In the past, both normal hematopoietic
|